Biomedical Engineering

...because open source matters

  • Increase font size
  • Default font size
  • Decrease font size
Home About CEMACUBE CEMACUBE explained

CEMACUBE Explained

In September 2010 the Erasmus Mundus Master’s course CEMACUBE (Common European MAster’s CoUrse in Biomedical Engineering) was initiated under the Erasmus Mundus Programme 2009-2013 of the European Commission and is currently running without support of the European Commission.

The goal of this course is to prepare students from Europe and outside Europe to improve health care by applying Biomedical Engineering. Therefore a consortium of 6 universities has joined their knowledge and specific expertise into a 2-year European Master’s in Biomedical Engineering. Biomedical Engineering is a broad multidisciplinary area, involving many sub-specializations, varying from regenerative medicine to implant design and from PET-scan imaging to biosensors. Only a consortium of various universities can teach all fields in BME.

Current-day medical practice relies increasingly on technology, such as microelectronics, information technology and mechanical and materials engineering. But technology can only improve health care when engineers and medical specialists work together. You will be trained to work in those interdisciplinary project teams. BME is the perfect mix of technology and health care.

  

alt

Programme structure

Courses

During the first two semesters, each university gives course elements on basic BME-topics. The content of those two semesters, offered by each consortium university is comparable and will contain:

Medical course elements (Anatomy and Histology, (Patho)physiology, Ethics);

General engineering course elements (Methodical Design, Project Management, Biochemistry, Bio transport, Working culture);

Engineering course elements, focused on diagnostics (Imaging Techniques, Biomedical Instrumentation, Signal Analysis);

Engineering course elements, focused on therapy (Cell Biology, Biomaterials, Biomechanics).

alt

 

A traineeship has to be followed in a hospital or industry in the first year. All universities of the consortium have an extensive network of contacts in hospitals and industries.

 

Specializations

In the second year, semester 1 the following specialisations can be chosen (given per university):

Aachen:  Artificial Organs & implants, Tissue Engineering

Dublin: (Neural Engineering), Tissue Engineering

Ghent: Radiation physics & Medical Imaging, Computational methods for medical applications

Groningen: Diagnostic Imaging and Instrumentation,  Protheses & Implant Interface Technology, Protheses & Implant Design

Prague: Medical Instrumentation, Medical Imaging Instrumentation

 

Research and Design

In semester 2 of year 2 an individual Master’s project will be performed. This project is a research or a design assignment. During this Master’s project all knowledge and skills learnedduring teh programme are applied:

To solve a problem by designing a device (in case of a design assignment)

To realise answers to a scientific question by performing scientific research (in case of a research assignment).

 

Mobility

Mobility is one of the key aspects of the CEMACUBE programme. The mobility of this Master's course makes it possible to switch between up to three universities in a total of two years. The programme consists of four semesters. During the first year (semester 1 and 2), a student will follow lectures on all biomedical engineering subjects at one of the partner Universities of Groningen (The Netherlands), Aachen (Germany), Dublin (Ireland), Ghent and Brussels (Belgium) and Prague (Czech Republic). In the second year the student will move to another partner university to follow lectures on a specific topic (semester 1)  and will do a Master’s project (semester 2). The Master’s project can also be done at one of the associated universities: Aalborg University, (Denmark), University of Calabria (Italy), Université de Technologie Compiègne (France), University of Patras (Greece), University of Strathclyde (United Kingdom), and the Institute of Biocybernetics and BME, Warsaw (Poland), ETH Zurich (Switzerland).

Last Updated on Friday, 23 June 2017 15:11  

Login Form